Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

INFLUENZA

DOI: https://doi.org/10.29296/25879979-2018-04-03
Download full text PDF
Issue: 
4
Year: 
2018

V.K. Pavlov; V.V. Skvortsov, MD; A.V. Kulinich; S.K. Mirzoyan; S.A. Vvedensky; Yu.A. Belova; Prof. A.V. Sabanov, MD Volgograd State Medical University 1, Pavshikh Bortsov Square, Volgograd 400066, Russian Federation

The paper considers the etiology, pathogenesis, symptomatology, and current approaches to treating influenza.
Keywords: 
influenza
intoxication syndrome
hemagglutinin
neuraminidase
interferon preparations

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Brooks M.J., Sasadeusz J.J., Tannock G.A. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline. Curr. Opin. Pulmonary Med. 2004; 10: 197.
  2. Shi L., Xiong H., He J., Deng H., Li Q., Zhong Q., Hou W., Cheng L., Xiao H., Yang Z. Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo. Arch Virol. 2007.
  3. Boriskin Y., Pecheur E., Polyak S. Arbidol: a broad-spectrum antiviral that inhibit acute and chronic HCV infection. Virology J. 2006; 3: 56.
  4. Boriskin Y., Leneva I., Pecheur E., Polyak S. Arbidol: a broad–spectrum antiviral compound that bloks viral fusion. Current Med. Chem. 2008; 15: 997–1005.
  5. Leneva I., Russel R.J., Boriskin Y., Hay A. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of Arbidol. Antiviral Research. 2009; 81 (2): 132–40.
  6. Megan J. Brooks, Elena I. Burtseva, et al. Antiviral Activity of Arbidol, a Broad-Spectrum Drug for Use Against Respiratory Viruses, Varies According to Test Conditions. J. Med. Virol. 2012; 84 (1): 170–81.
  7. Leneva I.A, Fedjakina I.T. Izuchenie protivovirusnoj aktivnosti otechestvennyh protivogrippoznyh himiopreparatov v kul'ture kletok i na modeli zhivotnyh. Voprosy virusologii. 2010; 55 (3).
  8. Eganjan G., Groppa L., Fazylov V. i dr. Lechenie ORVI i grippa v rutinnoj klinicheskoj praktike. Vrach. 2014; 2: 67–9.